Glibenclamide Tablets bulk supplier for pharma manufacturers

Glibenclamide Tablets 1.25 mg, 2.5 mg, 5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 1.25 mg, 2.5 mg, 5 mg

Reference Brands: Diabeta (USA), Euglucon (EU)

Category: Diabetes

Glibenclamide stimulates insulin secretion by binding to pancreatic β-cell sulfonylurea receptors, closing potassium channels, and triggering calcium influx. This enhances insulin release and reduces blood glucose levels. It effectively manages type 2 diabetes, especially in patients unresponsive to lifestyle changes alone, offering improved glycemic control and reduced hyperglycemic episodes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Glibenclamide tablets, also known as glyburide in the USA, are approved for the management of type 2 diabetes mellitus. In the USA, Glibenclamide is regulated under FDA-approved monographs and primarily marketed under brands like Diabeta and Micronase. In the EU, it is authorized through national procedures and widely available under brands such as Euglucon and generics from Sandoz and Teva. Due to the increased risk of hypoglycemia, especially in elderly patients, usage guidelines emphasize dose titration and caution in renal or hepatic impairment. Pharmatradz.com facilitates B2B sourcing of Glibenclamide across regulated markets.

Glibenclamide Tablets — third party manufacturing & bulk supply

Glibenclamide Tablets 1.25 mg, 2.5 mg, 5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Glibenclamide Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glibenclamide Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Glibenclamide Tablets →

Back to Listing

Frequently Asked Questions

Glibenclamide Tablets is listed as Tablets in 1.25 mg, 2.5 mg, 5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glibenclamide Tablets is referenced against Diabeta (USA), Euglucon (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.